Kura Oncology
KURA
KURA
182 hedge funds and large institutions have $474M invested in Kura Oncology in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 85 increasing their positions, 44 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 184 → 182 (-2)
4.75% less ownership
Funds ownership: 99.66% → 94.9% (-4.8%)
11% less capital invested
Capital invested by funds: $531M → $474M (-$57.2M)
Holders
182
Holding in Top 10
3
Calls
$434K
Puts
$261K
Top Buyers
| 1 | +$9M | |
| 2 | +$7.46M | |
| 3 | +$6.36M | |
| 4 |
Millennium Management
New York
|
+$4.69M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.26M |
Top Sellers
| 1 | -$26.4M | |
| 2 | -$7.28M | |
| 3 | -$5.23M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$3.97M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$3.84M |
